ClinicalTrials.Veeva

Menu

US National OCS Liver Perfusion (OLP) Registry (National OLP)

TransMedics logo

TransMedics

Status

Enrolling

Conditions

Liver Transplant

Treatments

Device: OCS Liver

Study type

Observational

Funder types

Industry

Identifiers

NCT05940857
OCS-LIVER-OLP-II

Details and patient eligibility

About

This Registry is a sponsor-initiated, multi-center, observational, post-approval registry with an independent academic oversight.

TransMedics has contracted with United Network for Organ Sharing (UNOS) the Federal manager of the U.S. national transplant outcomes registry to obtain data that is routinely collected by the Organ Procurement and Transplantation Network (OPTN) on all transplanted organs in the U.S. for both the OCS liver transplanted patients as well as patients transplanted using other preservation modalities. Additional data will be collected by participating centers using OCS Liver perfusion.

Enrollment

100,000 estimated patients

Sex

All

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

All liver transplant recipients.

Trial design

100,000 participants in 2 patient groups

OCS Liver Transplant Recipients
Description:
The US National OLP Registry will enroll all liver transplant recipients who are transplanted with an OCS-perfused donor liver in the Registry.
Treatment:
Device: OCS Liver
Non-OCS Liver Transplant Recipients
Description:
Patients transplanted using other preservation modalities for clinical outcomes.

Trial contacts and locations

22

Loading...

Central trial contact

Kelly Jork; Kausar Qidwai

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems